Effect neuromuscular blockade reversal with sugammadex on oxygenation, pain and arousal states in the post-anesthesia care unit - The Neuropa Study

Effect neuromuscular blockade reversal with sugammadex on oxygenation, pain and arousal states in the post-anesthesia care unit - The Neuropa Study - Neuropa

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON40831

Enrollment

100

Registered

2014-08-29

Start date

2014-10-28

Completion date

Unknown

Last updated

2024-04-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

anesthesie/spierverslapping anesthesia muscle relaxation

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Patients, ASA 1-3 undergoing elective general surgery, aged 18+ years, and BMI

Exclusion criteria

Exclusion criteria: Allergies for NMB agents; neuromuscular disorder; (family) history of malignant hyperthermia; pregnancy/lactating; intestinal obstruction, COPD Gold 4, bradycardia; neuraxial blockade; cognitive dysfunction; pulmonary disease with SpO2

Design outcomes

Primary

Measure	Time frame
SpO2	—

Secondary

Measure	Time frame
Pain score Sedation score Respiratory rate	—

Countries

Netherlands

Outcome results